Navigation Links
2011 ChemOutsourcing Record Attendance Marks 5th Year of Uninterrupted Growth of Annual Pharmaceutical Ingredients Show
Date:8/4/2011

LONG BRANCH, N.J., Aug. 4, 2011 /PRNewswire/ -- ChemOutsourcing today announced that this year's show has already eclipsed last year's attendance marking the 5th straight year of growth, reported Mark Alexay, its President. The annual chemistry and pharmaceutical ingredients show has emerged as an important business gathering of executives from Contract Research and Manufacturing organizations.

This year's show will take place September 12-15 , 2011 at Ocean Place Resort in Long Branch, NJ.

"Part of this year's growth is attributable to the larger pharmaceutical companies investing offshore to lower costs," remarked Alexay. "This has resulted in a growth spike in outsourcing. The industry supply chain has become increasingly globalized and the show is a good place for suppliers and their clients to meet. It also serves primarily the lucrative US market where everyone wants to be."

About 1000 attendees, 110 exhibitors, and 150 speakers attend ChemOutsourcing. Larger companies like Pfizer, Bristol-Myers Squibb, Merck, and Eli Lilly attend the show, and increasingly, small molecule biotech "emerging" pharmaceutical company chemists. The attendee list may be accessed at http://tinyurl.com/4xv8bo7

Alexay continued, "ChemOutsourcing started out as an API and intermediates show in 2007. Since then the show has evolved to include related areas like drug discovery, analytical development, laboratory equipment, and a variety of other pharmaceutical and chemical services. It's a long and convoluted food chain. And with new therapeutics now more difficult to discover and commercialize, everybody is looking for productive partnerships. So the industry has extended itself around the world and the show has grown with it."

The speaker and exhibitor lists can be viewed at http://tinyurl.com/3vxch7f

and

SOURCE ChemOutsourcing
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
2. Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort
3. Pharma ChemOutsourcing Show Seeking VCs to Address 100 Biotech Companies at September Event in Long Branch, NJ
4. NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011
5. Henry Schein Reports Record Second Quarter Results
6. Groupe Athena, Inc. Profits Soar on Record Revenues
7. Heritage Valley Health System Selects the Sunrise Acute Care Electronic Health Record from Allscripts
8. CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
9. RSB Spine, LLC, Announces Record Second-Quarter 2011 Revenue
10. AAIPharma Services Builds Compliance Record at Lab, Manufacturing and Packaging Operations
11. Porter Novelli Named Agency of Record for Prix Galien USA Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... May 18, 2011 The Consumer Healthcare Products ... acetaminophen medicines for children, applauds the U.S. Food ... and caregivers give their children the right amount ... Committee and Pediatric Advisory Committee recommended enhancing the ...
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... neuro-otologic, vestibular and neurological testing, said today that ... control and analysis software. Clinical specialists ... conduct vestibular, oculomotor and optokinetic tests to detect ...
Cached Medicine Technology:OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2
(Date:7/10/2014)... The benefits of medical imaging far outweigh the risks ... Way, with The Right Radiation Dose. However, overuse and ... Clinic is leading a collaborative effort to ensure a ... online in the Journal of Patient Safety , ... Commission, the Intersociety Accreditation Commission, and the Centers for ...
(Date:7/10/2014)... (July 10, 2014) A research review identifying the ... important first step in the process of developing evidence-based ... a new report published by Neurosurgery ... Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , Based on ...
(Date:7/10/2014)... localized prostate cancer were more likely to be ... effective treatments and survived for shorter times than ... UCLA study has found. , The negative outcomes ... as bias against the mentally ill, depression,s impact ... of investment in his general health and disinterest ...
(Date:7/10/2014)... new drug could prove useful in treating small cell lung ... Scientists from the Cancer Research UK Manchester Institute, based at ... Research Centre, teamed up with experts at AstraZeneca, as part ... known as AZD3965 - on small cell lung cancer ... Cancer Research , also helps identify which patients are most ...
(Date:7/9/2014)... 10, 2014 -- The World Health Organization recommends that ... moderate to vigorous physical activity (MVPA) each day. ... MVPA during school hours. Therefore, it stands to ... increase MVPA. In a new study scheduled for ... confirmed that time spent outdoors after school was positively ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:New drug active against most aggressive type of lung cancer cells 2Health News:Go play outside! Outdoor time promotes physical activity in youth 2
... is,a leader in serving people who are visually impaired -- ... People who are legally blind can function and lead effectively ... The news that Lt. Gov. Paterson will become Governor ... people with vision loss can,achieve great heights., As I ...
... the finding shouldn,t keep physicians from using Avastin, researchers say ... cancer drug Avastin can cause kidney damage by doing what ... study shows. , Avastin, whose generic name is bevacizumab, is ... attack cancers by cutting off their blood supply. It does ...
... 12 As previously,disclosed in its Form 8-K filed ... NHWK ) announced that Ernest G. Ludy has resigned,from ... of Directors for,personal reasons. As a result of such ... with Nasdaq Marketplace Rule,4350(d)(2) -- which requires the company,s ...
... Omega T, an Omega 3 and Turmeric ... ... makers,of Conquer HA(TM), introduce the latest addition to their family of joint,relief ... T,is powerful natural anti-inflammatory formula containing Omega 3 and,Turmeric for double strength ...
... 2008) The American Society of Nephrology (ASN), in ... American Society of Pediatric Nephrology (ASPN), will celebrate the ... and patient advocates from across the nation will hold ... raise awareness of chronic kidney disease (CKD) as a ...
... observed that cancer cells perform energy metabolism in a way ... later, this observation was exploited by clinicians to better visualize ... not been known exactly how tumor cells perform this alternate ... essential for tumor growth. , Now, two papers appearing in ...
Cached Medicine News:Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3Health News:Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market 2Health News:The Makers of Conquer HA(TM) Launch All-Natural Double Strength Anti- Inflammatory Formula 2Health News:ASN members visit Capitol Hill to promote World Kidney Day and CKD awareness 2Health News:Study helps explain fundamental process of tumor growth 2Health News:Study helps explain fundamental process of tumor growth 3
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
The staple fixation system provides a simple means of attaching tissue to bone....
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
Medicine Products: